Biofourmis Clinical Trials™ vs Habitu Health Usage & Stats

Biofourmis Clinical Trials™ empowers clinical trial participants with a user-friendly mobile app tailored to enhance your engagement and contribution to clinical research. Leveraging advanced technology, our platform provides personalized solutions tailored to meet the unique needs of your trial participation, seamlessly integrating into your daily life. Easily connect with your trial team and access study-related information. Contribute to data collection via connected devices, and access digital tools including informed consent, remote data capture, and virtual visits to actively engage in your trial journey. Our app offers educational resources and complete support for managing devices, promoting a seamless and supportive trial experience. Disclaimer: To access the Biofourmis Clinical Trials™ app, you must seek advice and study screening from a participating clinician. The app is for data collection purposes only, and does not make any diagnosis or clinical recommendations. You should directly seek advice from a health care provider before making any medical decisions. Questions about Biofourmis Clinical Trials? Email support@biofourmis.com
  • Apple App Store
  • Free
  • Medical

Store Rank

- -

Habitu is a new application built for clinical trials to allow participants a different trial experience, involving their families and members of their support cycle. Allowing a more efficient and better experience of clinical trial.
  • Apple App Store
  • Free
  • Health & Fitness

Store Rank

- -

Biofourmis Clinical Trials™ vs. Habitu Health ranking comparison

Compare Biofourmis Clinical Trials™ ranking trend in the past 28 days vs. Habitu Health

Rank

No Data Available

Biofourmis Clinical Trials™ vs. Habitu Health ranking by country comparison

Compare Biofourmis Clinical Trials™ ranking trend in the past 28 days vs. Habitu Health

No Data to Display

Compare to any site with our free trial

Get started
Biofourmis Clinical Trials™ VS.
Habitu Health

December 30, 2024